Epzicom

Product manufactured by Viiv Healthcare Company

Application Nr Approved Date Route Status External Links
NDA021652 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Epzicom, In Combination With Other Antiretroviral Agents, Is Indicated For The Treatment Of Human Immunodeficiency Virus Type 1 (hiv‑1) Infection. Epzicom, A Combination Of Abacavir And Lamivudine, Both Nucleoside Analogue Hiv-1 Reverse Transcriptase Inhibitors, Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments